Zahrawi Group, in collaboration with our esteemed partner BD, successfully hosted the ๐๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ฑ ๐๐๐๐ผ๐น๐ผ๐ด๐ ๐ฆ๐๐บ๐ฝ๐ผ๐๐ถ๐๐บ at ๐ฆ๐ผ๐ณ๐ถ๐๐ฒ๐น ๐๐ฏ๐ ๐๐ต๐ฎ๐ฏ๐ถ ๐๐ผ๐ฟ๐ป๐ถ๐ฐ๐ต๐ฒ. The event brought together leading experts to discuss challenging cases in gynecologic and thyroid cytology, guided by the renowned Bethesda Guidelines.
The program provided a comprehensive overview of key topics, including challenging cases in gynecologic cytology, thyroid cytology, and the future of cervical cancer screening.
We were honored to have Dr. Syed Ali and Dr. Rawia Mohamed as our special guest speakers.
Dr. Syed Ali, renowned for his expertise in Cytopathology and his insights into challenging cases in Gynae and Thyroid Cytology, is also the Co-Author of the Bethesda Thyroid Cytology guidelines. Dr. Rawia Mohamed shared her extensive expertise on recent trends in cervical cancer screening, offering valuable updates on advancements in this critical area of women’s health.
By hosting the ๐๐ฑ๐๐ฎ๐ป๐ฐ๐ฒ๐ฑ ๐๐๐๐ผ๐น๐ผ๐ด๐ ๐ฆ๐๐บ๐ฝ๐ผ๐๐ถ๐๐บ in partnership with BD, Zahrawi Group underscored its commitment to advancing healthcare, fostering innovation, and enhancing diagnostic practices in cytology across the region.